Key Facts
- Noteless raises €3.5 million in new Seed funding to expand its AI-powered clinical documentation platform to more European markets and support wider adoption among clinicians.
- More than 25% of general practitioners in Norway are currently using Noteless, according to CEO William Vossgård.
- Clinicians report that Noteless is providing them with up to two hours a day that they can spend with patients or on their own wellbeing.
- Noteless addresses a major inefficiency in healthcare with its AI-driven technology, claims Lucas Paul, Investment Director at Redstone.
Norwegian HealthTech startup Noteless raises €3.5 million in new Seed funding in order to expand its AI-powered clinical documentation platform to more European markets and support wider adoption among clinicians.
EU-Startups